ロード中...
Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive
Patients with BRAF V600 (BRAF) mutated metastatic melanoma are eligible for therapy with both immune checkpoint inhibitors and targeted therapies, making treatment choice a complex decision. The present study aimed to describe patterns of treatment with immunotherapy and targeted therapy and BRAF te...
保存先:
| 出版年: | Melanoma Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494034/ https://ncbi.nlm.nih.gov/pubmed/30247203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CMR.0000000000000504 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|